Viatris Inc. (VTRS) Stock Overview
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
About Viatris Inc.
Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and…
Source: Yahoo Finance
Sector & Industry
Viatris Inc. operates in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry group. It is listed on the NASDAQ exchange.
Viatris Inc. at a Glance
| Company | Viatris Inc. |
| Ticker | VTRS |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $17.29 |
| Market cap | $20.14B |
| P/E ratio (trailing) | — |
| EPS (trailing) | $-0.30 |
| 52-week high | $17.67 |
| 52-week low | $8.63 |
| Dividend yield | 2.78% |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Employees | 30,000 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Evaluating pharma pipelines, devices and healthcare economics.
Check Price →A practical framework for judging whether a dividend is safe and worth owning.
Check Price →Top-rated books on building an income portfolio from dividend payers.
Check Price →Frequently Asked Questions
What is Viatris Inc.'s P/E ratio?
Viatris Inc. (VTRS) has a trailing P/E ratio of — as of our latest data snapshot.
What is Viatris Inc.'s market cap?
Viatris Inc.'s market capitalisation is $20.14B based on the most recent snapshot.
What is VTRS's 52-week range?
Over the past 52 weeks, VTRS has traded between $8.63 and $17.67.
For compound interest, percentage change and other investing maths, try our free online calculators.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Related Healthcare Stocks
Data snapshot: 18 July 2026 (Yahoo Finance) · Page last built: